Vitreoretinal Surgery Devices Market to Witness Dynamic Growth at an Increased CAGR of 7.73% Reaching USD 2.45 Billion by 2026, Research Report | DelveInsight

The demand for Vitreoretinal Surgery Devices is primarily being boosted by the rising prevalence of eye diseases like retinal detachment, age-related macular degeneration, diabetic retinopathy, and epiretinal membrane, as well as the entrance of major players, among others are expected to drive the Vitreoretinal Surgery Devices market growth during the forecasting period.

LAS VEGAS, March 28, 2022 /PRNewswire/ -- DelveInsight's Vitreoretinal Surgery Devices Market Insights and Forecast report provides the current and forecast Vitreoretinal Surgery Devices Market, upcoming innovation in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Vitreoretinal Surgery Devices Market. 

Some of the key takeaways from the Vitreoretinal Surgery Devices Market report: 

• As per DelveInsight analysis, in terms of revenue share, North America is predicted to register the fastest growth in the Vitreoretinal Surgery Devices market.
• Some of the Global Vitreoretinal Surgery Device companies producing products in various stages include Bausch & Lomb Incorporated, Alcon Inc., Dutch Ophthalmic Research Center (International) B.V., OCULUS Optikgeräte GmbH, Paragon Care Group Australia Pty Ltd., MedOne Surgical, Inc., Zeiss Group, Geuder AG, Topcon Corporation, IRIDEX Corporation, Ellex Medical Lasers, Quantel Medical, MEDA Co., Ltd., Lumenis, NIDEK CO., LTD., Lightmed Corporation, Oertli Instrumente AG, BVI Medical, Johnson & Johnson Vision, OPTIKON, among others.
• DelveInsight analyzes that the Global Vitreoretinal Surgery Devices Market was valued at USD 1.57 billion in 2020, growing at a CAGR of 7.73% during the forecast period from 2021 to 2026 to reach USD 2.45 billion by 2026. 
• In July 2021, Aldeyra Therapeutics, Inc. announced the FDA  orphan drug designation for ADX-2191 (methotrexate for intravitreal injection) for the treatment of primary vitreoretinal lymphoma (PVRL).
• In December 2019, BVI Medical acquired Arcadophtha SARL (Arcad), a France-based ophthalmic company specializing in silicone oils, gases, and perfluorocarbons used in vitreoretinal surgery. 
• Growth in the Vitreoretinal Surgery Devices Market will be accelerated through the broad-reaching commercial infrastructure of BVI established with the Vitreq line of vitreoretinal surgical products.
• In July 2019 Bausch + Lomb announced the launch of the FreeFlow infusion system for retina surgery and the 23-gauge Bi-Blade dual-port vitrectomy cutter for the Stellaris Elite vision enhancement system.
• In June 2019, ZEISS India introduced FCI Vitreoretinal surgical devices in India. The FCI products were made available through an exclusive partnership between ZEISS India and FCI (France Chirurgie Instrumentation) S.A.S. This partnership offered the end-users a wide variety of options, which contributed to the growth of the Vitreoretinal Surgery Devices Market.

To pick on the latest highlights related to Vitreoretinal Surgery Devices market, get the snapshot of the key highlights entailed in the Vitreoretinal Surgery Devices Market Report

Vitreoretinal Surgery Devices Overview 

Vitreoretinal surgery is done to treat the retina, macula, and vitreous fluid-associated eye diseases. These include macular degeneration, retinal detachment, vitreous hemorrhage and uveitis, macular void, epiretinal membrane, retinal detachment, and diabetic retinopathy-associated complications. These are different types of devices with varied applications during vitreoretinal surgery.

Vitreoretinal Surgery Devices Market Insight 

Geographically, the Global Vitreoretinal Surgery Devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share North America currently leads the Global Vitreoretinal Surgery Devices market and is expected to remain constant during the forecast period. This domination is owing to significant growth factors such as the increasing prevalence of eye diseases, rising prevalence of the geriatric population, rising cases of diabetes that leads to eye disorders, and rising government initiatives for creating awareness regarding less invasive procedures are expected to aid in the growth of North America Vitreoretinal Surgery Devices Market.

Along with the factors mentioned above, the conducive environment for product development and launches in the country further motivates the key Vitreoretinal Surgery Devices market players to enhance their presence in North America. For instance, in July 2021, Aldeyra Therapeutics, Inc. announced the FDA orphan drug designation for ADX-2191 for primary Vitreoretinal Lymphoma treatment.

Click here to understand more about the key players in the Vitreoretinal Surgery Devices Market and their future @ Vitreoretinal Surgery Devices Future Assessment

Vitreoretinal Surgery Devices Market Dynamics 

The demand for Vitreoretinal Surgery Devices is primarily being boosted by the rising prevalence of eye diseases like retinal detachment, macular degeneration, diabetic retinopathy, and epiretinal membrane which is the leading cause of Vitreoretinal Surgery Devices market growth. Moreover, the rising geriatric population base, growing prevalence of lifestyle disorders such as diabetes, innovations in product development, and growing adaptability of less invasive procedures are expected to drive the Vitreoretinal Surgery product demand thereby contributing to the growth of the Vitreoretinal Surgery Devices global market during the forecast period. In addition to that, technological advancements in the product type and related approvals by the government are other key factors responsible for the growth of the Global Vitreoretinal Surgery Devices market.

However, on the other hand, postoperative complications of Vitreoretinal Surgery and retinal toxicity of medical devices used during Vitreoretinal Surgery may be certain impeding factors to Vitreoretinal Surgery Devices market growth. Further, the outbreak of the COVID-19 pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospital procedures. This resulted in the reduced number of routine clinical examinations of the ophthalmic and related procedures leading to a decrement in the Vitreoretinal Surgery Devices market growth.

To gain a better understanding of the COVID-19 impact on Vitreoretinal Surgery Devices, get a snapshot of the COVID-19 Impact On Vitreoretinal Surgery Devices Market

Scope of the Vitreoretinal Surgery Devices Market Report

• Coverage: Global
• Study Period: 2021-2026
• Market Segmentation By Product Type - Photocoagulation Surgery Devices, Vitrectomy Systems, Illumination Surgery Devices, Vitreoretinal Prefilled Silicone Oil Syringes, Others
• Market Segmentation By Type - Surgical Packs, Systems, Accessories, and Disposables
• Market Segmentation By End-User- Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centres
• Market Segmentation By Geography - North America, Europe, Asia-Pacific, and Rest of World
• Key Vitreoretinal Surgery Devices Companies - Bausch & Lomb Incorporated, Alcon Inc., Dutch Ophthalmic Research Center (International) B.V., OCULUS Optikgeräte GmbH, Paragon Care Group Australia Pty Ltd., MedOne Surgical, Inc., Zeiss Group, Geuder AG, Topcon Corporation, IRIDEX Corporation, Ellex Medical Lasers, Quantel Medical, MEDA Co., Ltd., Lumenis, NIDEK CO., LTD., Lightmed Corporation, Oertli Instrumente AG, BVI Medical, Johnson & Johnson Vision, OPTIKON, among others.
• Porter's Five Forces Analysis
• Product Profiles
• Case Studies 
• KOL's Views
• Analyst's View

Delveinsight Analysis: The Global Vitreoretinal Surgery Devices Market was valued at USD 1.57 billion in 2020, growing at a CAGR of 7.73% during the forecast period from 2021 to 2026 to reach USD 2.45 billion by 2026. 

Know more about which MedTech player is set to emerge as the trendsetter in the Global Vitreoretinal Surgery Devices Market @ Key Vitreoretinal Surgery Devices Companies Analysis 

Table of Contents 

Learn more about the report offerings @ Vitreoretinal Surgery Devices Market Outlook

Related Reports

Myopia Treatment Devices Market 

DelveInsight's 'Myopia Treatment Devices Market Insights, Competitive Landscape and Market Forecast-2026' report delivers an in-depth understanding of myopia treatment devices and the historical and forecasted Myopia Treatment Devices market trends, market drivers, market barriers, and key Myopia Treatment Devices companies involved such as CooperVision, Johnson & Johnson Vision (Acuve), Essilor Ltd., Bausch & Lomb Incorporated, Visioneering Technologies, Inc., LUCID KOREA, ALCON VISION LLC, Carl Zeiss Meditec AG, SynergEyes, Hoya Lens, STAAR Surgical Company, Paragon, and others.

Cataract Surgery Devices Market

Global Cataract Surgery Devices Market was valued at USD 7.34 billion in 2020, growing at a CAGR of 5.49% during the forecast period from 2021 to 2026 to reach USD 10.08 billion by 2026. The report delivers an in-depth understanding of the Cataract Surgery Devices Market and the historical and forecasted Cataract Surgery Devices market trends, market drivers, market barriers and key Cataract Surgery Devices companies involved such as Alcon Inc (Novartis), Johnson & Johnson Vision Care, NIDEK CO., LTD, ZEISS Group, Bausch & Lomb Incorporated, ROWIAK GmbH, Ziemer Ophthalmic Systems, HOYA Corporation, CRISTALENS, Aurolab, Hanita Lenses, Altacor, Bohus BioTech AB, Eyekon Medical, CIMA Technology Inc, and many others.

Ophthalmic Viscoelastic Devices Market

DelveInsight's 'Ophthalmic Viscoelastic Devices Market Insights, Competitive Landscape and Market Forecast - 2026' report delivers an in-depth understanding of Ophthalmic Viscoelastic Devices and the historical and forecasted Ophthalmic Viscoelastic Devices market trends, market drivers, market barriers, and key Ophthalmic Viscoelastic Devices companies involved such as Bausch Health Companies, Eyekon Medical Inc, Bohus Biotech Ab, Carl Zeiss Meditec AG, Cima Technology Inc, Johnson & Johnson, Novartis International AG (Alcon Inc.), Rumex International Corporation, Haohai Biological Technology, Altacor, and several others.

Ophthalmic Ultrasound Systems Market

DelveInsight's 'Ophthalmic Ultrasound Systems Market Insights, Competitive Landscape and Market Forecast - 2026' report delivers an in-depth understanding of Ophthalmic Ultrasound Systems and the historical and forecasted Ophthalmic Ultrasound Systems market trends, market drivers, market barriers and key Ophthalmic Ultrasound Systems companies involved such as HAAG-Streit Holding AG, Johnson & Johnson, Nidek Co., Ltd., MicroMedical Devices, Sonomed Escalon, Quantel Medical, Keeler, DGH Technology, Inc., and others

Age-related Vision Dysfunction Market

DelveInsight's 'Age-related Vision Dysfunction Market Insights, Epidemiology, and Market Forecast—2030' report delivers an in-depth understanding of the Age-related Vision Dysfunction, historical and forecasted epidemiology, current and forecasted Age-related Vision Dysfunction market size, market drivers, market barriers, unmet medical and key Age-related Vision Dysfunction companies involved like Orasis Pharmaceuticals, Alkeus Pharmaceuticals, Kodiak Sciences, Roche, Novartis, Nicox Ophthalmics, un Pharma Advanced Research Company Limited, Gyroscope Therapeutics, Kubota Vision, and others.

Dry Eye Disease Market

DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Dry Eye Disease, historical and forecasted epidemiology, current and forecasted Dry Eye Disease market size, market drivers, market barriers, and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Eye Neoplasms Market

DelveInsight's "Eye Neoplasms Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Eye Neoplasms, historical and forecasted epidemiology as well as the Eye Neoplasms market trends, current Eye Neoplasms treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Eye Infections Pipeline 

"Eye Infections Pipeline Insights, 2021" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Eye Infections market. A detailed picture of the Eye Infections pipeline landscape is provided, which includes the disease overview and Eye Infections treatment guidelines.

Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology

DelveInsight's 'Vasomotor symptoms (Hot flashes/Night sweats) Epidemiology Forecast2030' report delivers an in-depth understanding of the Vasomotor symptoms including Hot flashes or night sweats, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Other Trending DelveInsight Reports

• Cocaine Use Disorder Market
• Zollinger-ellison syndrome Market
• Chronic Myelocytic Leukemia Market
• Noonan Syndrome Market
• Plasmacytoma Market
• B cell Lymphomas Market
• TCR Therapy Market
• Spinal Trauma Devices Market 
• PCSK9 Market
• Stem Cell Market

Interested to know more about the breakthrough happenings? Take a look at the posts below 

• MedTech Industry Roars Back as FDA Approvals Soar
• Medical Devices Market Blooms as the Key MedTech Companies Continue to Bring-In Innovation
• Wearable Devices: Weighing the Potential Benefits and Pitfalls of the Innovative Wearable Products
• Thyroid eye disease market: New therapies enter the TED market
• Unity's advanced vascular eye disease trial
• How Pharmaceutical Companies Are Mitigating The Gap In The Eye Disorders Treatment Market

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. 

Connect With Us at LinkedIn | Facebook | Twitter

Contact Us
Shruti Thakur 
info@delveinsight.com 
+1(919)321-6187 
www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg